EPIDERMAL GROWTH FACTOR RECEPTOR
Clinical trials for EPIDERMAL GROWTH FACTOR RECEPTOR explained in plain language.
Never miss a new study
Get alerted when new EPIDERMAL GROWTH FACTOR RECEPTOR trials appear
Sign up with your email to follow new studies for EPIDERMAL GROWTH FACTOR RECEPTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can surgery or radiation boost control of advanced lung cancer after targeted therapy?
Disease control Recruiting nowThis study looks at whether adding surgery or radiation to the main tumor can help people with advanced EGFR-mutant lung cancer who have already responded to a combination of osimertinib and chemotherapy. About 70 adults will receive local therapy and be followed to see how long …
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE2 • Sponsor: Pusan National University Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug EPI-326 enters first human tests for tough cancers
Disease control Recruiting nowThis early-phase study tests a new drug called EPI-326 in about 110 people with advanced lung cancer (with a specific EGFR gene change) or head/neck cancer. The main goal is to check safety and find the best dose. Participants receive the drug and are monitored for side effects a…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for lung cancer patients with brain spread after standard treatment fails
Disease control Recruiting nowThis study tests a new treatment for people with a specific type of lung cancer (EGFR-mutant non-small cell lung cancer) that has spread to the lining of the brain and spinal cord (leptomeningeal metastasis) and has stopped responding to the drug osimertinib. The treatment combin…
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE2 • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
Scientists test new scan to unlock secrets of aggressive brain tumors
Knowledge-focused Recruiting nowThis study is testing a new combined MRI and PET scan to measure how brain tumors use energy. Researchers will compare scan results with tissue samples from 50 adults with glioblastoma who need surgery. The goal is to improve imaging, not to treat the disease directly.
Matched conditions: EPIDERMAL GROWTH FACTOR RECEPTOR
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 18, 2026 12:13 UTC